1296.5000 -15.40 (-1.17%)
NSE Mar 13, 2026 15:31 PM
Volume: 1.6M
 

Deven Choksey
Aurobindo Pharma’s wholly owned subsidiary, Aurobindo Pharma USA Inc., has entered into a definitive agreement with Lannett Seller Holdco, Inc. to acquire 100% membership interest in Lannett Company LLC.
Aurobindo Pharma Ltd. has an average target of 1332.89 from 9 brokers.
More from Aurobindo Pharma Ltd.
Recommended